| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.34 | 0.5 |